You are here: Industry Insights > HPV

News List

With nod in older adults, Merck drives HPV shot Gardasil 9 into big new market biospectrum
October 09, 2018
With HPV vaccine uptake slow to take off in the U.S. way back when, Merck & Co.'s Gardasil shots missed out on many eligible patients.
HPV jab will be given to boys in England, gov’t confirms pharmatimes
July 26, 2018
The government has confirmed that boys in England will be vaccinated against the human papilloma virus in line with recent recommendations from the Joint Committee on Vaccination and Immunisation (JCVI).
JCVI backs HPV jab for boys pharmatimes
July 25, 2018
The Lancet has published full results of a Phase II trial showing the benefit of Lilly’s JAK inhibitor Olumiant in the treatment of global systemic lupus erythematosus (SLE).
Researcher uses HPV vaccine to treat patient with skin cancer europeanpharmaceuticalreview
July 05, 2018
Evidence suggests the human papillomavirus plays a role in the development of some types of this skin cancer…
HPV vaccine slashes rate of infection by 86% in UK pharmafile
June 22, 2018
Since the introduction of the vaccination against the Human Papilloma Virus in 2008, there has been an 86% drop in the incidence of infection in women aged 16 to 21.
Boosted by China launch, Merck's Gardasil turns in a big first-quarter performance fiercepharma
May 09, 2018
Even as Merck's Gardasil sales suffer in the U.S. from the CDC's decision to implement a two-dose regimen, the HPV vaccine franchise posted strong growth in the first quarter as a China launch begins to pay off.
HPV vaccine found to prevent childhood respiratory papillomatosis europeanpharmaceuticalreview
November 13, 2017
The vaccine that protects against cancer-causing types of human papillomavirus also prevents an uncommon but incurable childhood respiratory disease…
HPV vaccine associated with improved fertility europeanpharmaceuticalreview
September 21, 2017
Researchers have examined the relationship between the HPV vaccination and fertility and identified that the vaccine can improve chances of conception…
Merck's Gardasil faces 'negative impact' of HPV schedule change: exec fiercepharma
February 08, 2017
Merck’s blockbuster HPV franchise Gardasil, the blockbuster vaccine could see some trouble in the U.S. this year, Merck is advising.
Cytovation announces appointment of Ole-Erik Iversen as Scientific Advisor firstwordpharma
January 23, 2017
Cytovation AS, a privately held biotech company developing CyPep-1 for the treatment of skin disorders announces the appointment of Professor Ole-Erik Iversen as Scientific Advisor.

Previous page 1 2 3 4 5 6 Next page